US FDA’s Califf Notes ‘Price To Pay’ For Missed Inspections During Senate COVID Funding Hearing

 
• By Brenda Sandburg

As Senate HELP Committee meetings questioned Commissioner Califf about backlog of inspections and FDA staff continuing to work remotely, Sen. Burr promises to be a roadblock to emergency COVID-19 funding.

COVID funding
Congress questions US FDA policies in dispute over COVID-19 emergency funding. • Source: Shutterstock

More from Manufacturing

More from Business